Renaissance Capital logo

China-focused blank check Longevity Acquisition prices $40 million US IPO at $10

August 29, 2018
4D pharma (Longevity Acquisition) logo

Longevity Acquisition, a blank check company focused on acquiring a business in China, raised $40 million by offering 4.0 million units at $10. Units consist of one ordinary share, one warrant to purchase one-half of one share exercisable at $11.50 per whole share, and one right for one-tenth of one share upon the acquisition. 

Longevity Acquisition plans to list on the Nasdaq under the symbol LOACU. Cantor Fitzgerald acted as a lead manager on the deal.